The launch of SYNBIOCHEM, the Manchester Centre for Fine and Speciality Chemicals, will be marked by special events to showcase the new capabilities based in the Manchester Institute of Biotechnology. The new state-of-the-art facility, supported by a dedicated team of expert researchers, will develop an innovative integrated suite of technologies for the synthesis of fine and speciality chemicals founded upon the application of predictive methods in SynBio.
The “Kick Off” meeting on June 11th will highlight the aims and objectives of the Centre, placed within the context of the Synthetic Biology Roadmaps which will ensure the place of the UK as global leaders in the field.
An Industry Event on June 12th will explore industry perspectives and develop collaborative interactions leading to SynBio solutions for fine and speciality chemcials.
To register your interest, please email: firstname.lastname@example.org
Synthetic biology aims at the rational design of biological systems and living organisms using engineering principles, to achieve new useful functions in a modular, reliable and predictable way. It has the potential to drive a new industrial revolution in biotechnology, with applications in many sectors, including healthcare, sustainable energy, green chemistry, pharmaceuticals, novel materials and bioremediation.
Synthetic biology requires cutting-edge research at the interface of biology, engineering, chemistry and computing science. The Manchester Institute of Biotechnology has assembled one of the strongest interdisciplinary teams with world-class expertise in all these areas in a single state-of-the-art facility. SYNBIOCHEM based at the MIB is actively engaged in challenging research projects that enable us to make significant advances in science to benefit industry and society. We currently maintain a portfolio that is already providing synbio solutions to the green manufacture of fine chemicals, therapeutic small molecules and new routes to biofuels.
Click here to download the event flyer: